Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates.
about
Recent Advances in the Diagnosis and Treatment of Clostridium Difficile InfectionDeterminants of Clostridium difficile Infection Incidence Across Diverse United States Geographic LocationsA comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection.The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study.Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.Rising Stakes for Health Care-Associated Infection Prevention: Implications for the Clinical Microbiology LaboratoryOverdiagnosis of Clostridium difficile Infection in the Molecular Test Era.A mathematical model to evaluate the routine use of fecal microbiota transplantation to prevent incident and recurrent Clostridium difficile infection.Clostridium difficile Infections in Veterans Health Administration Long-Term Care Facilities.Failure of Risk-Adjustment by Test Method for C. difficile Laboratory-Identified Event Reporting.A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure.A Multicenter Pragmatic Interrupted Time Series Analysis of Chlorhexidine Gluconate Bathing in Community Hospital Intensive Care Units.Clostridium difficile infections in Veterans Health Administration acute care facilities.High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients.National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014.Estimating Local Costs Associated With Clostridium difficile Infection Using Machine Learning and Electronic Medical Records.Impact of the introduction of a nucleic acid amplification test for Clostridium difficile diagnosis on stool rejection policies.Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)National Surveillance for Clostridioides difficile Infection, Sweden, 2009-2016
P2860
Q26766112-3BDF8524-7FC5-4466-9E42-34E4AA83D5AFQ34801846-09EBA971-EB9D-4405-841F-12233141A0E4Q35518053-99F35BF3-BE89-46F3-B40B-C81228731DBFQ35793012-213D6305-7A64-42E1-9BB7-FA2AFB6A197BQ36053985-D1E4F9BF-4D9A-4337-92EC-DCAFBA65178FQ36260465-F3DFCC66-431F-4D40-87FE-C9773898EFAFQ37103258-5E1FEBB7-79A6-45F5-B48A-8D51C866A10BQ37688458-B4CE53D1-1CD2-4FB7-BE9F-2B4357C0D5B0Q40190305-42D460D0-6032-4802-867F-B8F6A516935CQ40505285-1EBFB9B5-6ABB-4472-AD5E-679C7440E61BQ40521134-D779EC71-0758-452E-843C-F4297A64D7B2Q40798072-80E89AED-C580-4A5D-B4DC-573B76FAB4FBQ42206075-CCD9B3A2-B770-442A-ACB0-5CE47E7C1F1FQ42217150-73EC98E0-A856-4A39-BDE3-0351E0C2BDE1Q45325656-DE3AD7CD-1C45-444C-BF3F-5250EF112AA5Q45944171-2F5F0386-EA69-4882-A482-E1D34D51F0D2Q55030142-9C200D48-1F27-4B43-8C11-42A9F95EF888Q56225357-405A3042-ACBA-4DD2-93A4-722634E4964BQ58777719-324581FA-34B3-45CB-8ADE-A2B768B81A44
P2860
Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of change to molecular ...... ty-associated incidence rates.
@en
Impact of change to molecular ...... ty-associated incidence rates.
@nl
type
label
Impact of change to molecular ...... ty-associated incidence rates.
@en
Impact of change to molecular ...... ty-associated incidence rates.
@nl
prefLabel
Impact of change to molecular ...... ty-associated incidence rates.
@en
Impact of change to molecular ...... ty-associated incidence rates.
@nl
P2860
P50
P356
P1476
Impact of change to molecular ...... ity-associated incidence rates
@en
P2860
P304
P356
10.1086/673144
P577
2013-08-29T00:00:00Z